Johnson & Johnson (JNJ)
149.27
-0.65
(-0.43%)
USD |
NYSE |
May 03, 16:00
149.80
+0.53
(+0.36%)
Pre-Market: 07:35
Johnson & Johnson SG&A Expense (TTM): 21.93B for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 21.93B |
December 31, 2023 | 21.38B |
September 30, 2023 | 20.91B |
June 30, 2023 | 20.48B |
March 31, 2023 | 20.15B |
December 31, 2022 | 21.28B |
September 30, 2022 | 19.35B |
June 30, 2022 | 20.48B |
March 31, 2022 | 20.52B |
December 31, 2021 | 20.12B |
September 30, 2021 | 23.76B |
June 30, 2021 | 23.29B |
March 31, 2021 | 22.31B |
December 31, 2020 | 22.28B |
September 30, 2020 | 21.57B |
June 30, 2020 | 21.61B |
March 31, 2020 | 22.16B |
December 31, 2019 | 22.18B |
September 30, 2019 | 22.13B |
June 30, 2019 | 22.30B |
March 31, 2019 | 22.50B |
December 31, 2018 | 22.54B |
September 30, 2018 | 22.59B |
June 30, 2018 | 22.47B |
March 31, 2018 | 22.02B |
Date | Value |
---|---|
December 31, 2017 | 21.52B |
September 30, 2017 | 20.91B |
June 30, 2017 | 20.26B |
March 31, 2017 | 20.14B |
December 31, 2016 | 20.07B |
September 30, 2016 | 20.53B |
June 30, 2016 | 20.84B |
March 31, 2016 | 21.04B |
December 31, 2015 | 21.20B |
September 30, 2015 | 21.13B |
June 30, 2015 | 21.52B |
March 31, 2015 | 21.62B |
December 31, 2014 | 21.95B |
September 30, 2014 | 22.05B |
June 30, 2014 | 21.90B |
March 31, 2014 | 21.79B |
December 31, 2013 | 21.83B |
September 30, 2013 | 21.57B |
June 30, 2013 | 21.49B |
March 31, 2013 | 21.08B |
December 31, 2012 | 20.87B |
September 30, 2012 | 20.67B |
June 30, 2012 | 20.68B |
March 31, 2012 | 20.93B |
December 31, 2011 | 20.97B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
19.35B
Minimum
Sep 2022
23.76B
Maximum
Sep 2021
21.51B
Average
21.59B
Median
SG&A Expense (TTM) Benchmarks
Amgen Inc | 6.729B |
Eli Lilly and Co | 6.912B |
Merck & Co Inc | 10.51B |
Pfizer Inc | 14.85B |
Shockwave Medical Inc | 330.10M |